Alarfaj Abdullah A, Aldrweesh Abdulrahman Khalid, Aldoughan Alghaydaa Fouad, Alarfaj Sumaia Mohammed, Alabdulqader Fatimah Khalid, Alyahya Khalid A
Otolaryngology Unit, Department of Surgery, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
J Clin Med. 2023 Jul 18;12(14):4761. doi: 10.3390/jcm12144761.
COVID-19 is associated with a common symptom of olfactory dysfunction, which may persist even after the infection is resolved. Olfactory training (OT) has emerged as the most effective intervention for post-viral olfactory dysfunction. OT involves daily exposure of the olfactory system to various odors. The current study aims to explore olfactory dysfunction following COVID-19 and the potential benefits of olfactory training.
This is a cross-sectional study conducted among adults aged 18-60 living in Alahssa, Saudi Arabia. An online questionnaire containing an informed consent form and a survey to collect demographic data, vaccination status, level of loss of smell and taste, and the level of awareness about olfactory training (OT) was distributed among all participants who agreed to participate in this study.
The study included 524 participants and presented their baseline characteristics, including age, gender, COVID-19 infection status, and complaints. Most patients were female (66.0%), and 46.2% had previously been infected with COVID-19. About 54.8% of participants reported chemosensory dysfunction, while 286 had olfactory dysfunction. Of those, 29.8% had anosmia, 16.8% had hyposmia, and 8.0% had parosmia. Results suggest that being fully or partially vaccinated may offer some protection against olfactory dysfunction compared to being unvaccinated. Adherence to olfactory training was associated with improvement in the sense of smell.
The study highlights the importance of awareness and adherence to olfactory training, which may improve the sense of smell in individuals with chemosensory dysfunction. The findings of this study can inform public health policies and interventions aimed at reducing the burden of olfactory dysfunction associated with COVID-19 vaccination.
新型冠状病毒肺炎(COVID-19)与嗅觉功能障碍这一常见症状相关,即使感染已消除,该症状仍可能持续存在。嗅觉训练(OT)已成为治疗病毒感染后嗅觉功能障碍最有效的干预措施。OT包括让嗅觉系统每天接触各种气味。本研究旨在探讨COVID-19后的嗅觉功能障碍以及嗅觉训练的潜在益处。
这是一项在沙特阿拉伯阿拉哈萨居住的18至60岁成年人中进行的横断面研究。一份包含知情同意书以及用于收集人口统计学数据、疫苗接种状况、嗅觉和味觉丧失程度以及对嗅觉训练(OT)的认知程度的调查问卷,分发给所有同意参与本研究的参与者。
该研究纳入了524名参与者,并呈现了他们的基线特征,包括年龄、性别、COVID-19感染状况和主诉。大多数患者为女性(66.0%),46.2%的患者曾感染过COVID-19。约54.8%的参与者报告有化学感觉功能障碍,其中286人有嗅觉功能障碍。在这些人中,29.8%患有嗅觉丧失,16.8%患有嗅觉减退,8.0%患有嗅觉倒错。结果表明,与未接种疫苗相比,完全或部分接种疫苗可能对嗅觉功能障碍有一定的保护作用。坚持嗅觉训练与嗅觉改善相关。
该研究强调了对嗅觉训练的认知和坚持的重要性,这可能会改善化学感觉功能障碍个体的嗅觉。本研究结果可为旨在减轻与COVID-19疫苗接种相关的嗅觉功能障碍负担的公共卫生政策和干预措施提供参考。